MedTrace Logo

tDCS and VI to Treat Neuropathic Pain and Function in SCI

NCT03052244 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-02-14

No results posted yet for this study

Summary

Transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) will be applied for patient who suffer from neuropathic pain following spinal cord injury The tDCS treatment will be coupled with a video of a man walking (creating a visual illusion) in order to enhance functional ability and reduce pain

Conditions

  • SCI - Spinal Cord Injury

Interventions

DEVICE

tDCS+VI

2mA will be delivered over 20min to M1 via neuroConn DC stimulator combined with video presenting walking legs.

DEVICE

tDCS Sham+VI Sham

2mA will be delivered up to 30 sec to M1 via neuroConn DC stimulator combined with video presenting graphical illustration or nature movie for total duration of 20 min.

Sponsors & Collaborators

  • Loewenstein Hospital

    lead OTHER

Principal Investigators

  • Motti Ratmansky, MD · Loewenstein Rehabilitation Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2020-03-15
Completion
2020-03-15
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052244 on ClinicalTrials.gov